Quantcast

Fish Vet Group

Last update: April 9, 2019

Biotechnology
Norway Its 5 main executives

Recent executive movements at Benchmark Holdings

Peter George who is Chairman of the Board, will be promoted to Chairman of the Board and Chief Executive Officer on Nov. 30, 2019  (news posted on August 20 2019).
Malcolm Pye who is Chief Executive Officer and Director, will become Director on Nov. 30, 2019  (news posted on August 20 2019).
Septima Maguire will join the company as Chief Financial Officer in Nov. 2019  (news posted on August 15 2019).

Click here to view some more movements at Benchmark Holdings

Create an alert
to follow the executive moves at Fish Vet Group.

Latest M&A news in Biotechnology.

WebMD Health has announced the acquisition of Aptus Health (posted on Sep 30, 2019).
Castle Creek Pharmaceuticals has announced the acquisition of Fibrocell Science (posted on Sep 13, 2019).
Medicine Man Technologies has announced the acquisition of MedPharm (posted on Sep 12, 2019).

Latest news about Fish Vet Group

Fish Vet Group on Wikipedia, Google News & Yahoo Finance

Fish Vet Group on LinkedIn, Twitter & YouTube

Fish Vet Group has 1,318 competitors including Generation Bio (United States (USA)), Aldeyra Therapeutics (United States (USA)) and Alltech (United States (USA)). Fish Vet Group is owned by Benchmark Holdings.

The most constantly updated executive directory.

Companies

Companies

Learn about your clients' org charts. Understand their industries and their competitors.

Executives

Executives

View the executives' biographies. Contact the executives through our email platform.

Alerts

Alerts

Select key words to follow your clients. Receive alerts when executive movements happen.

Customers

Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.